
The success of the inhaled therapy is highly dependent on correct device use, patient motivation and therapy adherence. eFlow® Technology nebulizers together with the PARI Connect Platform are designed to improve inhalation treatments. With a forward-looking approach our in-house human factors engineering team performs and supports usability studies.
Hear from our experts regarding device usability and our digital solutions with the aim of increasing therapy adherence.
Martin Schlun, Director eFlow Development & Technology, shares insights on how we optimize the nebulizer usability and thus adherence.
Dr. Carola Fuchs, Director e-Health Solutions, talks about how we can add value to patients and ultimately to you as a partner with our digital solutions.

